Subclinical pulmonary function defects following autologous and allogeneic bone marrow transplantation: relationship to total body irradiation and graft-versus-host disease
- PMID: 2045296
- DOI: 10.1016/0360-3016(91)90231-r
Subclinical pulmonary function defects following autologous and allogeneic bone marrow transplantation: relationship to total body irradiation and graft-versus-host disease
Abstract
Pulmonary function results pre- and post-transplant, to a maximum of 4 years, were analyzed in 98 patients with haematological disorders undergoing allogeneic (N = 53) or autologous bone marrow transplantation (N = 45) between 1982 and 1988. All received similar total body irradiation based regimens ranging from 9.5 Gy as a single fraction to 14.4 Gy fractionated. FEV1/FVC as a measure of airway obstruction showed little deterioration except in patients experiencing graft-versus-host disease in whom statistically significant obstructive ventilatory defects were evident by 6 months post-transplant (p less than 0.01). These defects appeared to be permanent. Restrictive ventilatory defects, as measured by reduction in TLC, and defects in diffusing capacity (DLCO and KCO) were also maximal at 6 months post-transplant (p less than 0.01). Both were related, at least in part, to the presence of GVHD (p less than 0.01) or use of single fraction TBI with absorbed lung dose of 8.0 Gy (p less than 0.05). Fractionated TBI resulted in less marked restricted ventilation and impaired gas exchange, which reverted to normal by 2 years, even when the lung dose was increased from 11.0 Gy to between 12.0 and 13.5 Gy. After exclusion of patients with GVHD (30% allografts) there was no significant difference in pulmonary function abnormalities between autograft and allograft recipients.
Similar articles
-
Fractionated total body irradiation and allogeneic bone marrow transplantation for standard risk leukemia.Radiother Oncol. 1989 Dec;16(4):289-95. doi: 10.1016/0167-8140(89)90041-8. Radiother Oncol. 1989. PMID: 2694233
-
Total body irradiation correlates with chronic graft versus host disease and affects prognosis of patients with acute lymphoblastic leukemia receiving an HLA identical allogeneic bone marrow transplant.Int J Radiat Oncol Biol Phys. 1999 Feb 1;43(3):497-503. doi: 10.1016/s0360-3016(98)00441-6. Int J Radiat Oncol Biol Phys. 1999. PMID: 10078628
-
Graft-versus-leukemia in bone marrow transplantation. The Advisory Committee of the International Bone Marrow Transplant Registry.Bone Marrow Transplant. 1990 Jul;6 Suppl 1:94-7. Bone Marrow Transplant. 1990. PMID: 2390646
-
Bone marrow transplantation. The state of the art.Ann Ital Med Int. 1986 Jun;1(2):109-14. Ann Ital Med Int. 1986. PMID: 3079358 Review. No abstract available.
-
Pediatric bone marrow transplantation.Curr Opin Pediatr. 1993 Feb;5(1):103-9. doi: 10.1097/00008480-199302000-00016. Curr Opin Pediatr. 1993. PMID: 8374620 Review.
Cited by
-
Total body irradiation and pneumonitis risk: a review of outcomes.Br J Cancer. 2004 Jun 1;90(11):2080-4. doi: 10.1038/sj.bjc.6601751. Br J Cancer. 2004. PMID: 15150598 Free PMC article.
-
Pulmonary symptoms measured by the national institutes of health lung score predict overall survival, nonrelapse mortality, and patient-reported outcomes in chronic graft-versus-host disease.Biol Blood Marrow Transplant. 2014 Mar;20(3):337-44. doi: 10.1016/j.bbmt.2013.11.025. Epub 2013 Dec 4. Biol Blood Marrow Transplant. 2014. PMID: 24315845 Free PMC article.
-
Idiopathic pneumonia syndrome after bone marrow transplantation: the role of pre-transplant radiation conditioning and local cytokine dysregulation in promoting lung inflammation and fibrosis.Int J Exp Pathol. 2001 Apr;82(2):101-13. doi: 10.1111/j.1365-2613.2001.iep0082-0101-x. Int J Exp Pathol. 2001. PMID: 11454101 Free PMC article. Review.
-
Decline of forced expiratory volume in 1 s after allogeneic hematopoietic cell transplantation is a good indicator for pulmonary damage and is associated with busulfan use.Int J Hematol. 2019 Mar;109(3):299-308. doi: 10.1007/s12185-018-02581-y. Epub 2019 Jan 2. Int J Hematol. 2019. PMID: 30604314 Clinical Trial.
-
Genetic variation in bactericidal/permeability-increasing protein influences the risk of developing rapid airflow decline after hematopoietic cell transplantation.Blood. 2006 Mar 1;107(5):2200-7. doi: 10.1182/blood-2005-06-2338. Epub 2005 Nov 22. Blood. 2006. PMID: 16304058 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical